Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 26,355Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4NanoAlvand

02 9Incyte Corporation

03 22Novartis Pharmaceuticals Australia Pty Limited

04 14Novartis Pharmaceuticals Corporation

05 3Novartis South Africa (Pty) Ltd

06 3ORIFARM GROUP AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

05

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

06

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

07

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

08

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

09

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

10

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : OPZELURA

Dosage Form : CREAM;TOPICAL

Dosage Strength : EQ 1.5% BASE

Packaging :

Approval Date : 2021-09-21

Application Number : 215309

Regulatory Info : RX

Registration Country : USA

blank

11

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Ruxolitinib

Brand Name : Opzelura g

Dosage Form : Cream

Dosage Strength : 15mg

Packaging :

Approval Date : 30/01/2025

Application Number : 69443

Regulatory Info : Allowed

Registration Country : Switzerland

blank

12

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

13

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 15mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

14

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 20mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

15

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

16

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Oral Solution

Dosage Strength : 5mg/ml

Packaging :

Approval Date : 27/03/2025

Application Number : 69722

Regulatory Info : Allowed

Registration Country : Switzerland

blank

17

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date : 03/10/2014

Application Number : 20140311000017

Regulatory Info : Approved

Registration Country : Sweden

blank

18

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 15 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

19

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 20 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

20

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 5 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank